We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Immunoassays for Human Saliva Need Validation

By LabMedica International staff writers
Posted on 12 Mar 2012
Print article
Saliva has gained considerable attention as a possible alternate diagnostic fluid to blood because it is easily accessible and convenient to collect.

Commercial enzyme-linked immunosorbent assays (ELISAs) have proven to be a powerful tool for fast and reliable sample analysis, however few ELISAs have been validated for use with saliva, or their validation is often incomplete.

Scientists at Newcastle University (Newcastle upon Tyne, UK) collected from healthy volunteers 5-10 mL of saliva and gingival crevicular fluid (GCF) which is the primary source of inflammatory mediators in saliva. They analyzed and validated commercially available assays for 13 common biomarkers of inflammation and bone resorption, relevant for diseases such as rheumatoid arthritis and periodontitis.

The following ELISAs were assessed for their use with human saliva: C-reactive protein (CRP), hepatocyte growth factor (HGF), interleukin 1β (IL-1β), IL-6, matrix metalloproteinases -3 (MMP-3), MMP-8, MMP-9, Regulated on Activation cytokine (Rantes), tissue inhibitor of metalloproteinases-1 (TIMP-1) (Quantikine; R&D Systems, Abingdon, UK), albumin, hemoglobin (Bethyl Laboratories; Cambridge, UK), collagen telopeptides (Wampole Laboratories; Princeton, NJ, USA) and elastase (Hycult Biotech; Cambridge, UK).

A range of viscosity for the analyzed saliva samples was found which could be graded (subjectively) anywhere from very fluid to highly viscous. Various degrees of viscosity are mainly due to different amounts of large glycoproteins, such as mucins. Handling the highly viscous samples required special attention to pipetting techniques, and in some cases “reverse” pipetting instead of “forward” was considered to improve accuracy and to reduce pipetting errors.

Of all evaluated assays, only three, MMP-8, MMP-9, and TIMP-1 were recommended for use with saliva by the manufacturer. To fit within the range of each standard curve, most assays required a different sample dilution than that recommended for serum samples, which had to be determined empirically. A recovery between 80% and 120% is generally accepted as a good indication that the assay is suitable for use with the tested sample. With the exception of collagen telopeptides, recovery of the analyzed assays was within or very close to this range

The authors concluded that most ELISAs are suitable for analysis of saliva samples, even if this is not specifically recommended by the manufacturer. However, they believe that an independent validation of assays for saliva samples is important, as they have highlighted a number of cases in which validation and quality control analysis for some assays yielded questionable results when using saliva. The study was published in the March 2012 issue of the Journal of Immunological Methods.

Related Links:
Newcastle University
R&D Systems
Bethyl Laboratories

New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
Verification Panels for Assay Development & QC
Seroconversion Panels
New
H.pylori Test
Humasis H.pylori Card
New
Lyme Disease Test
Lyme IgG/IgM Rapid Test Cassette

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.